| Cause | Details |
|---|---|
| Post-surgical (#1) | After thyroidectomy or parathyroidectomy -parathyroid glands damaged/removed |
| Autoimmune | Autoimmune polyendocrine syndrome type 1 (APS-1) |
| Hypomagnesemia | Mg < 1.0 → impaired PTH secretion AND PTH resistance. Fix Mg first! |
| Infiltrative | Hemochromatosis, Wilson disease, metastatic cancer |
| DiGeorge syndrome | 22q11 deletion -absent parathyroids + thymic aplasia |
| Cause | Mechanism | Key Feature |
|---|---|---|
| Post-surgical (most common) | Parathyroid glands damaged or removed during thyroidectomy/parathyroidectomy | Hypocalcemia within 24–72h post-op; may be transient or permanent |
| Autoimmune | Autoimmune destruction of parathyroid glands (APS-1: AIRE gene mutation) | Associated with mucocutaneous candidiasis, adrenal insufficiency |
| DiGeorge syndrome | 22q11.2 deletion → absent/hypoplastic parathyroids | Congenital: cardiac defects, thymic aplasia, characteristic facies |
| Hypomagnesemia (functional) | Mg < 1.0 → impaired PTH secretion AND end-organ PTH resistance | PTH is low despite low calcium; calcium won't correct until Mg repleted |
| Infiltrative (hemochromatosis, Wilson) | Iron/copper deposition in parathyroid glands destroys tissue | Look for liver disease, skin changes; check ferritin, ceruloplasmin |
| Setting | Treatment | Details |
|---|---|---|
| Acute | IV Calcium Gluconate | 1–2g IV over 10 min; preferred for peripheral IV (less tissue necrosis) |
| Continuous calcium drip | 0.5–1.5 mg/kg/hr elemental calcium; titrate to ionized Ca q4–6h | |
| Cardiac monitoring | Continuous telemetry -prolonged QTc → torsades risk; correct Mg simultaneously | |
| Chronic | Calcitriol (Rocaltrol) | 0.25–2 mcg daily -active vitamin D (bypasses PTH-dependent activation) |
| Calcium Carbonate (Tums) | 1–3g elemental calcium daily in divided doses with food | |
| Thiazide diuretics | Reduce urinary calcium excretion → prevent nephrocalcinosis/kidney stones | |
| Natpara (recombinant PTH) | PTH replacement for refractory cases; reduces calcium/calcitriol requirements |
| Drug | Dose | Purpose |
|---|---|---|
| Calcium Gluconate | 1–2g IV over 10–20 min | Acute symptomatic hypocalcemia -peripheral IV safe |
| Calcium Chloride | 1g IV | 3× more elemental Ca than gluconate -central line only (tissue necrosis risk) |
| Calcitriol (Rocaltrol) | 0.25–2 mcg daily | Active vitamin D -replaces PTH-dependent activation |
| Calcium Carbonate (Tums) | 500–1500 mg elemental Ca TID | Chronic oral replacement. Take with food (needs acid for absorption). |
| Magnesium Sulfate | 2–4g IV | Correct hypomagnesemia FIRST -calcium won't correct otherwise |
Patient: 54F, post-op day 1 from total thyroidectomy for papillary thyroid carcinoma. Reports perioral tingling and fingertip numbness.
Exam: Chvostek sign positive (facial twitch on tapping). Trousseau sign positive. HR 88, BP 118/72.
Labs: Total Ca 6.8 mg/dL (low), ionized Ca 0.82 mmol/L (low), PO₄ 5.2 (high), PTH < 5 pg/mL (low), Mg 2.0 (normal).
ECG: Prolonged QTc at 510 ms.
Management:
Key lesson: Post-thyroidectomy hypocalcemia is the #1 cause of hypoparathyroidism. Always monitor calcium in the first 24–72h post-op. Symptomatic patients need IV calcium urgently.
Patient: 8-month-old male with known 22q11.2 deletion (DiGeorge syndrome), history of tetralogy of Fallot repair. Presents with generalized tonic-clonic seizure lasting 2 minutes.
Labs: Ionized Ca 0.7 mmol/L (critically low), total Ca 5.9 mg/dL, PO₄ 7.1 (high), PTH < 3 pg/mL, Mg 1.8 (normal).
Management:
Key lesson: DiGeorge syndrome = absent parathyroids + thymic aplasia. Seizures in DiGeorge should trigger immediate calcium check. These patients need lifelong replacement -no chance of parathyroid recovery.
Patient: 62F with chronic hypoparathyroidism (post-thyroidectomy 8 years ago), on calcitriol 1 mcg BID + calcium carbonate 1.5g TID. Presents with flank pain. CT shows bilateral nephrocalcinosis.
Labs: Total Ca 9.2 (normal on replacement), 24h urine Ca 420 mg (elevated, normal < 300), creatinine 1.4 (baseline 0.9), PO₄ 4.8.
Problem: Without PTH, kidneys cannot reabsorb calcium → chronic hypercalciuria → nephrocalcinosis → renal damage despite normal serum calcium.
Management:
Key lesson: Chronic hypoparathyroidism management is a balancing act. Aim for low-normal serum Ca to minimize urinary calcium losses. Thiazides and PTH replacement (Natpara) are key tools for preventing nephrocalcinosis.